The TNF-α antagonist etanercept reverses age-related decreases in colonic SERT expression and faecal output in mice

Bhavik Anil Patel, Sara Fidalgo, Chunfan Wang, Leena Parmar, Kasonde Mandona, Annabelle Panossian, Melanie Flint, Richard Ranson, Jill Saffrey, Mark Yeoman

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)
18 Downloads (Pure)

Abstract

Treatment for chronic constipation in older people is challenging and the condition has a major impact on quality of life. A lack of understanding about the causes of this condition has hampered the development of effective treatments. 5-HT is an important pro-kinetic agent in the colon. We examined whether alterations in colonic 5-HT signalling underlie age–related changes in faecal output in mice and whether these changes were due to an increase in TNF-α. Components of the 5-HT signalling system (5-HT, 5-HIAA, SERT) and TNF-α expression were examined in the distal colon of 3, 12, 18 and 24-month old mice and faecal output and water content monitored under control conditions and following the administration of etanercept (TNF-α inhibitor; 1 mg Kg−1). Faecal output and water content were reduced in aged animals. Age increased mucosal 5-HT availability and TNF-α expression and decreased mucosal SERT expression and 5-HIAA. Etanercept treatment of old mice reversed these changes, suggesting that age-related changes in TNFα expression are an important regulator of mucosal 5-HT signalling and pellet output and water content in old mice. These data point to “anti-TNFα” drugs as potential treatments for age-related chronic constipation.
Original languageEnglish
Pages (from-to)42754
JournalScientific Reports
Volume7
DOIs
Publication statusPublished - 15 Feb 2017

Fingerprint

Dive into the research topics of 'The TNF-α antagonist etanercept reverses age-related decreases in colonic SERT expression and faecal output in mice'. Together they form a unique fingerprint.

Cite this